126 related articles for article (PubMed ID: 10083618)
1. The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618
[No Abstract] [Full Text] [Related]
2. GvHD after small bowel transplantation: the role of caspases, FAS-L, and galectin-1.
Fändrich F; Zepernick-Kalinski C; Lin X
Transplant Proc; 1998 Sep; 30(6):2594-5. PubMed ID: 9745506
[No Abstract] [Full Text] [Related]
3. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
4. CD95L confers immune priviledge to liver grafts which are spontaneously accepted.
Fändrich F; Lin X; Zhu X; Klöppel G; Parwaresch R; Kremer B
Transplant Proc; 1998 Jun; 30(4):1057-8. PubMed ID: 9636427
[No Abstract] [Full Text] [Related]
5. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.
Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplantation; 1999 May; 67(10):1295-300. PubMed ID: 10360580
[TBL] [Abstract][Full Text] [Related]
6. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
Hare GM; Lee TD; Jordan JL; Hirsch GM
Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
[No Abstract] [Full Text] [Related]
7. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
Subbotin V; Sun H; Chen C; Aitouche A; Valdivia L; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1998 Jun; 30(4):941-2. PubMed ID: 9636378
[No Abstract] [Full Text] [Related]
8. Contribution of Fas ligand to cardiac allograft rejection.
Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues during small intestinal graft rejection in rats.
Park YJ; Fujisaki S; Kimizuka K; Shugito K; Tomita R; Fukuzawa M; Matsumoto K
Transplant Proc; 2004 Mar; 36(2):353-5. PubMed ID: 15050157
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular biology of chronic rejection.
Häyry P; Alatalo S; Myllärniemi M; Räisänen-Sokolowski A; Lemström K
Transplant Proc; 1995 Feb; 27(1):71-4. PubMed ID: 7879153
[No Abstract] [Full Text] [Related]
11. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis is involved in acute cardiac allograft rejection in rats.
Kageyama Y; Li XK; Suzuki S; Suzuki H; Suzuki K; Kazui T; Harada Y
Ann Thorac Surg; 1998 Jun; 65(6):1604-9. PubMed ID: 9647066
[TBL] [Abstract][Full Text] [Related]
13. Role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen.
Minagawa R; Okano S; Tomita Y; Shimizu I; Iwai T; Kishihara K; Nomoto K; Sugimachi K; Nomoto K
Transplant Proc; 2001; 33(1-2):283. PubMed ID: 11266820
[No Abstract] [Full Text] [Related]
14. Use of CD14 and lipopolysaccharide binding protein mRNA expression as markers for acute rejection in rat small bowel transplantation.
Cicalese L; Freeswick PD; Watkins SC; Kelly E; Zeidan M; Rao AS; Stanko RT
Transplant Proc; 1996 Oct; 28(5):2470. PubMed ID: 8907907
[No Abstract] [Full Text] [Related]
15. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
16. The role of alloantigen-independent factors in transplant arteriosclerosis.
Kouwenhoven EA; Marquet RL; Bonthuis F; IJzermans JN; de Bruin RW
Transplant Proc; 1997 May; 29(3):1721-2. PubMed ID: 9142246
[No Abstract] [Full Text] [Related]
17. An orthotopic aortic graft mouse model to study the immunopathology of chronic vascular rejection.
Thomsen M; Dambrin C; Uro-Coste E; Subra C; Britton S; Joffre O; Calise D; Arbiol C; Thiers JC; Bayard F; Blaes N; Benoist H
Transplant Proc; 2002 Nov; 34(7):2833-5. PubMed ID: 12431626
[No Abstract] [Full Text] [Related]
18. Regulation of Fas ligand-induced apoptosis by TNF.
Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
[TBL] [Abstract][Full Text] [Related]
19. Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts.
Walgenbach KJ; Heeckt PF; Stanson JD; Whiteside TL; Bauer AJ
Transplant Proc; 1996 Oct; 28(5):2454. PubMed ID: 8907896
[No Abstract] [Full Text] [Related]
20. An investigation into the effects of cyclosporine and FK 506 on the progress of chronic rejection in the rat aortic model.
Cole OJ; Stubington SR; Rigg KM; Shehata M
Transplant Proc; 1998 Jun; 30(4):991. PubMed ID: 9636400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
